Tag

Bristol-Myers Squibb Company

1 article

AstraZeneca, Bristol-Myers Squibb Discuss $400bn Merger

AstraZeneca and Bristol‑Myers Squibb have been in merger talks, targeting a combined valuation near $400 billion, per FT report. AstraZeneca market cap ~ $264 bn; BMS ~ $133 bn; shares closed at $169.